维普期刊资源整合服务平台（V6.5）

32篇 您的检索式：作者名="Lars Wallentin"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	In Situ Etching for Total Control Over Axial and Radial Nanowire Growth显示文摘We report a method using in situ etching to decouple the axial from the radial nanowire growth pathway,independent of other growth parameters.Thereby a wide range of growth parameters can be explored to improve the nanowire properties without concern of tapering or excess structural defects formed during radial growth.We demonstrate the method using etching by HCl during InP nanowire growth.The improved crystal quality of etched nanowires is indicated by strongly enhanced photoluminescence as compared to reference nanowires obtained without etching.	Magnus T.Borgström Jesper Wallentin Johanna Trägårdh Peter Ramvall Martin Ek LReine Wallenberg Lars Samuelson Knut Deppert	2010	Nano Research2010，3，4：	4
2	Stent Thrombosis With Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes: An Analysis From the Prospective, Randomized PLATO Trial显示文摘	P. Gabriel Steg Robert A. Harrington H?kan Emanuelsson Hugo A. Katus Kenneth W. Mahaffey Bernhard Meier Robert F. Storey Daniel M. Wojdyla Basil S. Lewis Gerald Maurer Lars Wallentin Stefan K. James	2013	Circulation2013，，10：	2
3	Cardiac Biomarkers Are Associated With an Increased Risk of Stroke and Death in Patients With Atrial Fibrillation: A Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Substudy显示文摘	Ziad Hijazi Jonas Oldgren Ulrika Andersson Stuart J. Connolly Michael D. Ezekowitz Stefan H. Hohnloser Paul A. Reilly Dragos Vinereanu Agneta Siegbahn Salim Yusuf Lars Wallentin	2012	Circulation2012，，13：	2
4	Inhibitory Effects of Ticagrelor Compared With Clopidogrel on Platelet Function in Patients With Acute Coronary Syndromes显示文摘	Robert F. Storey Dominick J. Angiolillo Shankar B. Patil Bhaloo Desai Rosemary Ecob Steen Husted Hakan Emanuelsson Christopher P. Cannon Richard C. Becker Lars Wallentin	2010	Journal of the American College of Cardiology2010，，：	1
5	Association of Aspirin Dose and Vorapaxar Safety and Efficacy in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome (From the TRACER Trial)显示文摘	Kenneth W. Mahaffey Zhen Huang Lars Wallentin Robert F. Storey Lisa K. Jennings Pierluigi Tricoci Harvey D. White Paul W. Armstrong Philip E. Aylward David J. Moliterno Frans Van de Werf Edmond Chen Sergio Leonardi Tyrus Rorick Claes Held John Strony Robe	2013	The American Journal of Cardiology2013，，：	1
6	Relationship between clopidogrel-induced platelet P2Y12 inhibition and stent thrombosis or myocardial infarction after percutaneous coronary intervention—A case-control study显示文摘	Christoph Varenhorst Sasha Koul David Erlinge Bo Lagerqvist Agneta Siegbahn Lars Wallentin Stefan James	2011	American Heart Journal2011，，：	1
7	Growth Differentiation Factor-15 and Risk of Recurrent Events in Patients Stabilized After Acute Coronary Syndrome: Observations From PROVE IT-TIMI 22显示文摘	Marc P. Bonaca David A. Morrow Eugene Braunwald Christopher P. Cannon Songtao Jiang Stephanie Breher Marc S. Sabatine Tibor Kempf Lars Wallentin Kai C. Wollert	2011	Arteriosclerosis Thrombosis and Vascular Biology2011，，1：	1
8	Inhibitory Effects of Ticagrelor Compared With Clopidogrel on Platelet Function in Patients With Acute Coronary Syndromes显示文摘	Robert F. Storey Dominick J. Angiolillo Shankar B. Patil Bhaloo Desai Rosemary Ecob Steen Husted Hakan Emanuelsson Christopher P. Cannon Richard C. Becker Lars Wallentin	2010	Journal of the American College of Cardiology2010，，18：	1
9	5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study显示文摘	Bo Lagerqvist Steen Husted Fredrik Kontny Elisabeth St?hle Eva Swahn Lars Wallentin	2006	The Lancet2006，，9540：	1
10	Cystatin C: A Novel Predictor of Outcome in Suspected or Confirmed Non–ST-Elevation Acute Coronary Syndrome显示文摘	Tomas Jernberg Bertil Lindahl Stefan James Anders Larsson Lars-Olof Hansson Lars Wallentin	2004	Circulation2004，，16：	1
11	Usefulness of Biomarkers for Predicting Long-Term Mortality in Patients With Diabetes Mellitus and Non–ST-Elevation Acute Coronary Syndromes (A GUSTO IV Substudy)显示文摘	Stefan K. James Bertil Lindahl Jorik R. Timmer Jan Paul Ottervanger Agneta Siegbahn Mats Stridsberg Paul Armstrong Robert Califf Lars Wallentin Maarten L. Simoons	2006	The American Journal of Cardiology2006，，2：	1
12	Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial显示文摘	Lars Wallentin Salim Yusuf Michael D Ezekowitz Marco Alings Marcus Flather Maria Grazia Franzosi Prem Pais Antonio Dans John Eikelboom Jonas Oldgren Janice Pogue Paul A Reilly Sean Yang Stuart J Connolly	2010	The Lancet . 2010 (9745)2010，，9745：	1
13	Growth-differenti-ation factor-15 is an independent marker of cardiovascular dys-function and disease in the elderly:results from the Prospective In-vestigation of the Vasculature in Uppsala Seniors(PIVUS)Study显示文摘	Lars Lind Lars Wallentin Tibor Kempf	2009	European Heart Journal2009，30，：	1
14	Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials显示文摘	Eric Boersma Robert A Harrington David J Moliterno Harvey White Pierre Théroux Frans Van de Werf Anneke de Torbal Paul W Armstrong Lars C Wallentin Robert G Wilcox John Simes Robert M Califf Eric J Topol Maarten L Simoons	2002	The Lancet2002，，9302：	1
15	Ticagrelor Compared With Clopidogrel by Geographic Region in the Platelet Inhibition and Patient Outcomes (PLATO) Trial显示文摘	Kenneth W. Mahaffey Daniel M. Wojdyla Kevin Carroll Richard C. Becker Robert F. Storey Dominick J. Angiolillo Claes Held Christopher P. Cannon Stefan James Karen S. Pieper Jay Horrow Robert A. Harrington Lars Wallentin	2011	Circulation2011，，5：	1
16	N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease显示文摘	Tomas Jernberg Bertil Lindahl Agneta Siegbahn Bertil Andren Gunnar Frostfeldt Bo Lagerqvist Mats Stridsberg Per Venge Lars Wallentin	2003	Journal of the American College of Cardiology2003，，11：	1
17	N-Terminal Pro-Brain Natriuretic Peptide and Other Risk Markers for the Separate Prediction of Mortality and Subsequent Myocardial Infarction in Patients With Unstable Coronary Artery Disease: A Global Utilization of Strategies To Open occluded arteries (显示文摘	Stefan K James Bertil Lindahl Agneta Siegbahn Mats Stridsberg Per Venge Paul Armstrong Elliot S Barnathan Robert Califf Eric J Topol Maarten L Simoons Lars Wallentin	2003	Circulation2003，，3：	1
18	Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial显示文摘	Renato D Lopes Sana M Al-Khatib Lars Wallentin Hongqiu Yang Jack Ansell M Cecilia Bahit Raffaele De Caterina Paul Dorian J Donald Easton Cetin Erol Justin A Ezekowitz Bernard J Gersh Christopher B Granger Stefan H Hohnloser John Horowitz Elaine M Hylek Jo	2012	The Lancet2012，，9855：	1
19	Relationship between IL-6 and mortality in patients with unstable coronary artery disease显示文摘	Eva Lindmark Eric Diderholm Lars Wallentin	2001	JAMA2001，286，10：	1
20	Comparison of ticagrelor, the first reversible oral P2Y 12 receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial显示文摘	Stefan James Axel ?kerblom Christopher P. Cannon H?kan Emanuelsson Steen Husted Hugo Katus Allan Skene Philippe Gabriel Steg Robert F. Storey Robert Harrington Richard Becker Lars Wallentin	2009	American Heart Journal2009，，4：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示